|
gptkbp:instanceOf
|
oral contraceptive
|
|
gptkbp:activeIngredient
|
gptkb:FD&C_Red_No._40
gptkb:ethinyl_estradiol
gptkb:povidone
gptkb:FD&C_Blue_No._2
lactose
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
norgestimate
|
|
gptkbp:alternativeTo
|
gptkb:Ortho_Tri-Cyclen
gptkb:TriNessa
|
|
gptkbp:approvedBy
|
2001
|
|
gptkbp:broadcastOn
|
28-day cycle
|
|
gptkbp:containsEstrogen
|
gptkb:ethinyl_estradiol
|
|
gptkbp:containsProgestin
|
norgestimate
|
|
gptkbp:contraindication
|
gptkb:cancer
gptkb:liver_disease
history of thromboembolic disorders
known or suspected pregnancy
|
|
gptkbp:discontinued
|
yes
|
|
gptkbp:FDAApproved
|
yes
|
|
gptkbp:form
|
gptkb:tablet
triphasic
|
|
gptkbp:genericName
|
norgestimate and ethinyl estradiol tablets
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Tri-Sprintec
|
|
gptkbp:indication
|
prevention of pregnancy
|
|
gptkbp:marketedAs
|
gptkb:Teva_Pharmaceuticals
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
headache
breast tenderness
mood changes
weight change
|
|
gptkbp:tabletColor
|
blue
light blue
white
green (inactive)
|
|
gptkbp:usedFor
|
birth control
|
|
gptkbp:bfsParent
|
gptkb:ethinyl_estradiol
|
|
gptkbp:bfsLayer
|
7
|